复合Wallstent-Z支架行髂股静脉支架置入的长期结局
本研究回顾性分析了535例(545条肢体)因症状性慢性髂股静脉阻塞接受初始髂股静脉支架置入的患者,评估复合Wallstent-Z支架(复合支架)的临床与支架相关结局。结果显示,24个月时疼痛、肿胀、VCSS及生活质量均显著改善,60个月一期、一期辅助及二期通畅率分别为70%、99%和91%,复合支架配置不仅减少了对侧支架置入需求,还降低了对侧髂股深静脉血栓发生率。
要点
- 复合支架置入后24个月疼痛、肿胀、VCSS及生活质量均显著改善。
- 60个月一期、一期辅助及二期通畅率分别为70%、99%和91%。
- 复合支架减少对侧支架需求并降低对侧髂股深静脉血栓发生率。
核心结论
- 复合支架配置的临床改善、生活质量改善及支架通畅率与单独使用Wallstent相当,且减少对侧支架置入需求和对侧髂股深静脉血栓发生率。
研究设计与样本
- 回顾性审查2014至2017年4年间535例(545条肢体)因症状性慢性髂股静脉阻塞接受初始髂股静脉支架置入患者的电子病历数据,排除急性深静脉血栓干预后置入支架者。
主要发现
- 24个月时视觉模拟评分疼痛从5降至2(P < .0001),肿胀分级从3降至1(P < .0001),静脉临床严重程度评分从6降至4(P < .0001)。
- 67条肢体存在溃疡,中位随访26个月时49条(73%)愈合。
- 整体慢性静脉疾病生活质量问卷评分从60改善至36(P < .0001)。
- 60个月累积一期、一期辅助及二期通畅率分别为70%、99%和91%。
临床怎么用
- 对于症状性慢性髂股静脉阻塞,复合Wallstent-Z支架置入可改善疼痛、肿胀、严重程度评分及生活质量,并维持较高通畅率。
- 复合支架配置有助于减少对侧支架置入需求及对侧髂股深静脉血栓风险。
局限性
- 本研究为回顾性设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: An endovascular approach has essentially replaced open surgery in the management of symptomatic chronic obstructive iliofemoral venous disease. In the last several years, such a minimally invasive approach has shifted from use of Wallstents alone to a combination of Wallstent-Z stent (composite stenting) to better deal with the iliocaval confluence. This study evaluates the clinical and stent related outcomes following use of composite stenting. METHODS: A retrospective review of contemporaneously entered EMR data on 535 patients (545 limbs) with initial iliofemoral stents placed over a 4-year period from 2014 to 2017 for symptomatic chronic iliofemoral venous obstruction was performed. Patients who underwent stenting after intervention for acute deep venous thrombosis were excluded. The impact of stenting on clinical outcomes before and after the intervention were evaluated through use of the visual analog scale pain score (0-10), grade of swelling (0-4), and Venous Clinical Severity Score (0-27). Quality of life was appraised using the Chronic Venous Disease quality of life Questionnaire 20 instrument. Kaplan-Meier analysis was used to assess primary, primary assisted and secondary stent patencies, and paired and unpaired t-tests were used to examine clinical outcomes. RESULTS: Of the 545 limbs that underwent stenting, 183 were in men and 362 were in women. The median age was 60 years. Laterality was right in 205 limbs and left in 340 limbs. Post-thrombotic syndrome was seen in 441 limbs and nonthrombotic iliac vein lesions/May-Thurner syndrome in 104 limbs. At 24 months, visual analog scale pain score went from 5 to 2 (P < .0001), grade of swelling went from 3 to 1 (P < .0001), and Venous Clinical Severity Score went from 6 to 4 (P < .0001). Ulcers were present in 67 limbs and had healed in 49 limbs (73%) over a median follow-up of 26 months. Global Chronic Venous Disease quality of life Questionnaire scores improved from 60 to 36 (P < .0001) after stenting. Cumulative primary, primary-assisted, and secondary patencies at 60 months were 70%, 99% and 91%, respectively. Thirty limbs (5.5%) required contralateral stenting. There was only one instance (0.2%) of contralateral iliofemoral deep venous thrombosis. One hundred eleven limbs (20%) underwent reintervention, including for in-stent restenosis in 44 limbs, stent compression in 2 limbs, in-stent restenosis and stent compression in 48 limbs, and stent occlusion in 17 limbs. CONCLUSIONS: In patients undergoing iliofemoral venous stenting for obstructive disease, clinical improvement, quality of life improvement, and stent patencies after use of a composite stent configuration are comparable with those seen after exclusive use of Wallstents. However, the use of a composite stent configuration not only decreases the need for contralateral stenting to relieve chronic obstruction, but also decreases the incidence of contralateral iliofemoral deep venous thrombosis.
引用
- Jayaraj A, Noel C, Kuykendall R, et al. Long-term outcomes following use of a composite Wallstent-Z stent approach to iliofemoral venous stenting. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32827734. doi:10.1016/j.jvsv.2020.08.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。